Progestins (Progestagens)
*** Progestins are female sex hormones.
*** The natural ones are secreted mainly by the corpus luteum
    and placenta.
*** The most abundant natural progestin is progesterone.
***It is not active when taken orally, but synthetic progestins
   are active in oral doses.
Medicinal uses
1- As contraceptives in combination with estrogens.
2- Excessive uterine bleeding.
3- Dysmenorrhea.
                          Progesterone
                         (IM, vaginal gel)              CH3
                                                        C     O
                                                  CH3
                                        CH3
                             O
 Pregn-4-ene-3,20-dione.
** It is not effective orally, it is given parenterally, with very
    short duration (about 5 minutes).
*** It is used in combination with estrogens in contraceptives
    pills.
Assay
Spectrophotometrically at  max 241 nm (in absolute ethanol).
    A) Progestins derived from progesterone
       (17-Hydroxyprogesterone derivatives)
                     CH3                                             CH3
                     C     O                                         C     O
               CH3                                             CH3
                                                                           OH
    CH3                                         CH3
                               Hydroxylation
O                                          O
    Progesterone                               17-hydroxyprogesterone
                                                        (i) Esterification of 17-OH group.
                                                        (ii) Introduction of a substituent at C6.
                                                                   CH3
                                                                   C     O
                                                             CH3
                                                                         OCOR
                                               CH3
                                                   R'
        Compound                    R'          R        Administration
                                                             route
 
1- Hydroxyprogesterone hexanoate         H   (CH2)4CH3       IM
   (Hydroxyprogesterone caproate)
2- Medroxyprogesterone acetate      -CH3      CH3            Orally
          (Provera)
                                      
           1- Hydroxyprogesterone hexanoate
              (Hydroxyprogesterone caproate)
                                     CH3
                                     C     O   O
                               CH3
                                           O   C   (CH2)4CH3
                      CH3
             O
 17-Hydroxypregn-4-ene-3,20-dione hexanoate.
*** It is much more active and longer acting than progesterone,
    because the 17ester function hinders the reduction of
    the 20-One, to the 20-Ol.
*** It is given only IM.
*** The hexanoate ester greatly increases the oil solubility,
    decreases the rate of absorption and allowing it to be slowly
    released. Finally prolonged duration or depot action
              2- Medroxyprogesterone acetate
                        (Provera)   CH3
                                                  C   O   O
                                            CH3
                                                      O   C   CH3
                                CH3
                                      CH3
17-Hydroxy-6-methylpregn-4-ene-3,20-dione acetate.
Or 17-acetyloxy-6-methylpregn-4-ene-3,20-dione.
*** It contains 6-methyl group adds to the 17-
hydroxyprogesterone
    structure, this will greatly decrease the rate of reduction of the 4-
    en-3-one system.
*** The 17-acetate group also decreases reduction of the 20-one, just
     as with 17-caproate.
*** Medroxyprogesterone acetate is very active orally, and
    has much a long duration of action intramuscularly.
Uses
In oral contraceptives, treatment of menstrual disorders, endom
etrial carcinoma in addition to other uses for progestins.
Assay
Specrtophotometrically at  max 241 nm.
Structure activity relationship of this group:
1- All these compounds are strongly active progesterone more
   potent than progesterone itself.
 
2- Esterification of the OH group in C17 increase the lipid
   solubility and decrease the absorption from the site of
   injection so, it gives depot action. Also this ester moiety at
   C17 protects the (C=O) adjacent from being reduced by
    reductases through its steric effect (reduction in biological
    system is the reason of deactivation).
 
3- Substitution at the position 6 with methyl or chloro group
    will protect the 6 position and adjacent vulnerable sites
    from being biotransformed and biooxidized and thus
    rendering these compounds more potent, longer duration
    and orally active.
(B) Progestins derived from testosterone and
    nortestosterone (17-Ethinyltestosterone)
In these compounds the acetyl group at C17 in progesterone
 
is completely substituted by 17-hydroxy and 17-ethinyl
groups.
                   1- Ethisterone (oral)
                                                      OH
                                                CH3
                                                           C   CH
                                     CH3
17-Ethinyl-17-Hydroxyandrost-4-en-3-one.
It is progestational compound, it is highly orally active, and it
is used in oral contraceptives.
         2-    Norethindrone (Norethisterone)
                         (oral)
                                      OH
                                CH3
                                           C   CH
17-Ethinyl-17-Hydroxy-19-norandrost-4-en-3-one.
General characters of this group
1- They are more potent than natural hormone.
2- Orally active.
3- They are not biotransformed to corticosteroids.
4- They suffer from some side effects such as;
a- They have some androgenic properties as side effects, due
   to structural similarity to testosterone.
b- They have structural similarity to estrogens, therefore,
   they have estrogenic properties, due to the absence of
   CH3 group at carbon no.10, These estrogenic properties
   will inhibit ovulation by –ve feed back mechanism process
   by inhibition of LH and FSH (estrogenic side effects).
So these compounds are mainly progestional ones with some
estrogenic and androgenic properties as side effects.
Uses
They are involved in small doses in oral contraceptive pills as
progestional components.
Structure activity relationship
1- Presence of 4-en-3-one in ring (A) is essential for maximum
   activity, shifting of the double bond to 5(10) position gives a
   compound, which retains only 1/10 activity (norethynodrel).
2- 19-Nor derivatives (without methyl group ( no. 19) are more
   strong as progestational agents, the absence of CH3 group
   no. 19 helps the fitting of the compound to its receptors,
   therefore gives much potent progestational activity. So,
   norethisterone is more active than ethisterone.
3- The ethinyl group at C17 yields an orally active drug and
   prevents oxidation of C-17 OH into C17 (C=O) and protect
   C16-17 bond from attack by intestinal microflora.
4- Esterification at C17 will protect C=O at C20 and also protect
    bond at C16-17 bond and prevent its cleavage.
Assay of progestational compounds
O2N             NHNH2                        O2N                      NH   N
                        +
                            O
          NO2                                                   NO2
                                                       Highly coloured compound
                               Antiprogestins
                  CH3       Ru 486 (Mifepristone)
        H3C       N
                                             OH
                                       CH3
                                                   C       C     CH3
                  O
*** Ru 486 binds strongly with both the glucocorticoid
    receptor and with the progesterone receptor.
*** When progesterone binds to its receptor, heat shock
    protein is released from the receptor and thereby opens
    the progesterone-receptor complex to DNA binding.
*** However, when RU 486 binds to the progesterone receptor,
    heat shock protein is not released: therefore, no
    transcription of the DNA can occur.
*** Alternatively, RU 486 may induce a conformational change
    in the progesterone receptor so that it does not fit its DNA
    site.
*** Ru 486 is used also in the treatment of progesterone
    sensitive cancers and in Cushing’s syndrome
    (overproduction of glucocorticoides).